Help improve the diagnosis of CJD Learn more.

Help improve the diagnosis of CJD Learn more

About the article

Most Recent

News & Articles

Prion protein and RNA: a view from the cytoplasm

Since it was posited that a cytoplasmic isoform of PrP may be involved in prion diseases, controversies about the isoform's biogenesis and function have emerged in the literature. While the existence of cytoplasmic PrP in vivo and in different cell cultures systems has now been well-established, whether it has specific activity remains unknown. This review outlines recent evidence about the molecular activity of cytoplasmic PrP. Cytoplasmic PrP inhibits a normal cellular stress response by preventing the assembly of protective mRNA stress granules and the synthesis of heat-shock protein 70 following environmental stress. Interference with the stress response correlates with the coalescence of mRNAs in a large cytoplasmic ribonucleoprotein particle. This particle shares similarities with the chromatoid body, a particle that organizes and controls RNA processing in mammalian germ cells as well as in neurons and stem cells from planarians with high regenerative abilities.

Citation: Roucou X. Prion protein and RNA: a view from the cytoplasm. Front Biosci. 2009 Jun 1;14:5157-64.

full text article from publisher: 
Volume: 
14
Enter multiple addresses on separate lines
Source: 
Frontiers in Bioscience
Publication date: 
06/01/2009
authorcomp: 
Publisher: 
Frontiers in Bioscience

Post new comment

The content of this field is kept private and will not be shown publicly.
  • You may post PHP code. You should include <?php ?> tags.

More information about formatting options

Search All News And Articles - Advanced

Return To Simple Search
gggg
Your comments for Dr.
Your name

Your email address will only be used for communicating with you regarding your correspondence. We will not sell or give away your information.

CAUTION: For your protection, we remind you that this is an unsecured email service, which is not intended for sending confidential or sensitive information. Please do not include your personal medical information in the content of the email. Please read our privacy policy for more details.